Catherine Gallou

526 total citations
12 papers, 357 citations indexed

About

Catherine Gallou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Catherine Gallou has authored 12 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Catherine Gallou's work include Epigenetics and DNA Methylation (4 papers), Renal cell carcinoma treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Catherine Gallou is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Renal cell carcinoma treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Catherine Gallou collaborates with scholars based in France and Switzerland. Catherine Gallou's co-authors include Claudine Junien, Raymonde Bouvier, D Droz, Christophe Béroud, Arnaud Méjean, Natacha Martin, Richard J. Kahnoski, Dominique Joly, Claudine Deloménie and Rajagopal Krishnamoorthy and has published in prestigious journals such as Cancer Research, Oncotarget and Human Mutation.

In The Last Decade

Catherine Gallou

12 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Gallou France 7 259 173 96 67 47 12 357
Yang Cheng China 10 205 0.8× 105 0.6× 98 1.0× 37 0.6× 35 0.7× 26 321
Ana Teresa Martins Portugal 14 285 1.1× 139 0.8× 140 1.5× 91 1.4× 24 0.5× 25 486
Sabine Harlander Switzerland 7 260 1.0× 171 1.0× 128 1.3× 31 0.5× 42 0.9× 8 342
Daniel Onofre Vidal Brazil 13 389 1.5× 226 1.3× 76 0.8× 63 0.9× 30 0.6× 31 530
Graça Varzim Portugal 7 512 2.0× 188 1.1× 169 1.8× 79 1.2× 33 0.7× 7 589
Srikant Ambatipudi India 10 250 1.0× 102 0.6× 54 0.6× 77 1.1× 49 1.0× 17 380
Hailing Jin United States 10 183 0.7× 100 0.6× 118 1.2× 103 1.5× 65 1.4× 11 340
Yann Christinat Switzerland 10 227 0.9× 129 0.7× 87 0.9× 84 1.3× 26 0.6× 21 376
Yuxia Zhao China 12 193 0.7× 126 0.7× 69 0.7× 79 1.2× 17 0.4× 26 313
Tomasz Tyszkiewicz Poland 11 180 0.7× 99 0.6× 52 0.5× 70 1.0× 30 0.6× 20 319

Countries citing papers authored by Catherine Gallou

Since Specialization
Citations

This map shows the geographic impact of Catherine Gallou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Gallou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Gallou more than expected).

Fields of papers citing papers by Catherine Gallou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Gallou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Gallou. The network helps show where Catherine Gallou may publish in the future.

Co-authorship network of co-authors of Catherine Gallou

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Gallou. A scholar is included among the top collaborators of Catherine Gallou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Gallou. Catherine Gallou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Morales‐Kastresana, Aizea, Janet K. Peper-Gabriel, Lucia Pattarini, et al.. (2021). Abstract LB135: Simultaneous costimulatory T-cell engagement and checkpoint inhibition by PRS-344/S095012, a PD-L1/4-1BB bispecific compound for tumor localized activation of the immune system. Cancer Research. 81(13_Supplement). LB135–LB135. 1 indexed citations
2.
Gallou, Catherine, et al.. (2016). Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines. Annals of Translational Medicine. 4(14). 266–266. 21 indexed citations
3.
4.
Junien, Claudine & Catherine Gallou. (2004). Cancer Nutrigenomics. World review of nutrition and dietetics. 93. 210–269. 4 indexed citations
5.
Gallou, Catherine, Dominique Chauveau, Richard J. Kahnoski, et al.. (2004). Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Human Mutation. 24(3). 215–224. 68 indexed citations
6.
Gallou, Catherine, Arnaud Méjean, Raymonde Bouvier, et al.. (2004). Delineation of a 2.8 megabases region harboring a potential tumor suppressor gene involved in renal cell carcinoma, that is commonly deleted from chromosome 14.. PubMed. 23(6C). 4865–70. 2 indexed citations
7.
Gallou, Catherine, Dominique Chauveau, Richard J. Kahnoski, et al.. (2004). Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Human Mutation. 24(5). 435–436. 6 indexed citations
8.
Tisserand, Pascaline, Coralie Fouquet, Michel Barrois, et al.. (2003). Lack of HIN-1 Methylation Defines Specific Breast Tumor Subtypes Including Medullary Carcinoma of the Breast and BRCA1-Linked Tumors. Cancer Biology & Therapy. 2(5). 559–563. 13 indexed citations
9.
Gallou, Catherine, Claudine Deloménie, Arnaud Méjean, et al.. (2001). Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma. Pharmacogenetics. 11(6). 521–535. 23 indexed citations
10.
Junien, Claudine, Jean‐Marie Dupret, Catherine Gallou, et al.. (2000). Prévention du carcinome rénal : l’approche nutrigénétique. Journal de la Société de Biologie. 194(1). 29–38. 3 indexed citations
11.
Gallou, Catherine, Dominique Joly, F. Staroz, et al.. (1999). Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC. Human Mutation. 13(6). 464–475. 112 indexed citations
12.
Deloménie, Claudine, Catherine Gallou, Arnaud Méjean, et al.. (1999). Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.. PubMed. 59(12). 2903–8. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Ana Teresa Martins Breakdown of academic impact, for papers by Sabine Harlander Breakdown of academic impact, for papers by Daniel Onofre Vidal Breakdown of academic impact, for papers by Graça Varzim Breakdown of academic impact, for papers by Srikant Ambatipudi Breakdown of academic impact, for papers by Hailing Jin Breakdown of academic impact, for papers by Yann Christinat Breakdown of academic impact, for papers by Yuxia Zhao Breakdown of academic impact, for papers by Tomasz Tyszkiewicz
Rankless by CCL
2026